BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 28434416)

  • 1. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
    Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
    Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEALTH TECHNOLOGY ASSESSMENT IN EVALUATION OF PHARMACEUTICALS IN THE CZECH REPUBLIC.
    Vostalová L; Mazelová J; Samek J; Vocelka M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):339-344. PubMed ID: 28438231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.
    Lipska I; McAuslane N; Leufkens H; Hövels A
    Int J Technol Assess Health Care; 2017 Jan; 33(3):350-357. PubMed ID: 28720170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA.
    Benisheva-Dimitrova T; Sidjimova D; Cherneva D; Kralimarkov N
    Int J Technol Assess Health Care; 2017 Jan; 33(3):365-370. PubMed ID: 28831942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEVELOPMENT OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA.
    Scintee SG; Ciutan M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):371-375. PubMed ID: 28436346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE.
    Kani C; Kourafalos V; Litsa P
    Int J Technol Assess Health Care; 2017 Jan; 33(3):396-401. PubMed ID: 28756795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Policy in Slovakia.
    Bucek Psenkova M; Visnansky M; Mackovicova S; Tomek D
    Value Health Reg Issues; 2017 Sep; 13():44-49. PubMed ID: 29073987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
    Huic M; Tandara Hacek R; Svajger I
    Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA.
    Guzvic V; Catic T; Kostic M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):390-395. PubMed ID: 28434417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early dialogue with health technology assessment bodies: a European perspective.
    Cuche M; Beckerman R; Chowdhury CA; van Weelden MA
    Int J Technol Assess Health Care; 2014 Dec; 30(6):571-8. PubMed ID: 25816822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEALTH TECHNOLOGY ASSESSMENT IN SERBIA.
    Atanasijevic D; Zah V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):384-389. PubMed ID: 28662733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS).
    Serrano-Aguilar P; Asua-Batarrita J; Molina-López MT; Espallargues M; Pons-Rafols J; García-Armesto S; Arriola-Bolado P; López-García M; Faraldo-Vallés MJ; Sánchez-Gómez LM; Juárez-Rojo C; Prieto-Yerro I; Casado-Durández P; Sarria-Santamera A
    Int J Technol Assess Health Care; 2019 Jan; 35(3):176-180. PubMed ID: 31006412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
    Woodford Guegan E; Cook A
    Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Policy in Greece.
    Yfantopoulos JN; Chantzaras A
    Value Health Reg Issues; 2018 Sep; 16():66-73. PubMed ID: 30195093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
    Beletsi A; Koutrafouri V; Karampli E; Pavi E
    Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.